rs78892546
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_145038.5(DRC1):c.1067C>T(p.Ala356Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00625 in 1,614,120 control chromosomes in the GnomAD database, including 336 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_145038.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRC1 | NM_145038.5 | c.1067C>T | p.Ala356Val | missense_variant | 9/17 | ENST00000288710.7 | NP_659475.2 | |
DRC1 | XM_047446339.1 | c.47C>T | p.Ala16Val | missense_variant | 2/10 | XP_047302295.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRC1 | ENST00000288710.7 | c.1067C>T | p.Ala356Val | missense_variant | 9/17 | 2 | NM_145038.5 | ENSP00000288710 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00834 AC: 1269AN: 152168Hom.: 25 Cov.: 32
GnomAD3 exomes AF: 0.0143 AC: 3593AN: 251320Hom.: 141 AF XY: 0.0164 AC XY: 2227AN XY: 135842
GnomAD4 exome AF: 0.00603 AC: 8811AN: 1461834Hom.: 310 Cov.: 31 AF XY: 0.00770 AC XY: 5602AN XY: 727220
GnomAD4 genome AF: 0.00835 AC: 1271AN: 152286Hom.: 26 Cov.: 32 AF XY: 0.00974 AC XY: 725AN XY: 74462
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2018 | - - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Primary ciliary dyskinesia 21 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 21, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at